TY - JOUR
T1 - Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials
AU - Creek, Darren J.
AU - Charman, William N.
AU - Chiu, Francis C.K.
AU - Prankerd, Richard J.
AU - Dong, Yuxiang
AU - Vennerstrom, Jonathan L.
AU - Charman, Susan A.
PY - 2008/4
Y1 - 2008/4
N2 - The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.
AB - The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.
UR - http://www.scopus.com/inward/record.url?scp=42049102584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42049102584&partnerID=8YFLogxK
U2 - 10.1128/AAC.01033-07
DO - 10.1128/AAC.01033-07
M3 - Article
C2 - 18268087
AN - SCOPUS:42049102584
SN - 0066-4804
VL - 52
SP - 1291
EP - 1296
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 4
ER -